Tag: Nivolumab

Tag Visualization: Top 50 related tags by occurrence

Recent Related Articles to Nivolumab

Evolving Standards of Care in the Systemic Treatment of Metastatic Urothelial Cancer

Added to Collection on: 2024-07-14 16:18:05

Tags for this article:

Orphan drugs
Antineoplastic drugs
Cancer immunotherapy
Pembrolizumab
Transitional cell carcinoma
Atezolizumab
Enfortumab vedotin
Nivolumab
Avelumab
Bladder cancer
Checkpoint inhibitor
PD-1 and PD-L1 inhibitors
Cisplatin
Gemcitabine

Click the tags to see associated articles and topics

View Article Details
CatalYm Announces New Financing of $150M to Support Broad Phase 2b Development ...

Added to Collection on: 2024-07-16 14:33:48

Tags for this article:

Immune system
Cancer immunotherapy
Orphan drugs
Antineoplastic drugs
Checkpoint inhibitor
Nivolumab
Programmed cell death protein 1
Non-small-cell lung cancer
PD-1 and PD-L1 inhibitors
Cancer immunology
CatalYm

Click the tags to see associated articles and topics

View Article Details
Real-World Treatment Patterns and Outcomes of Cemiplimab in Patients w | CMAR

Added to Collection on: 2024-07-18 10:14:26

Tags for this article:

Antineoplastic drugs
Orphan drugs
Cemiplimab
Pembrolizumab
Gefitinib
Electrocorticography
Cohort study
Atezolizumab
Nivolumab
Skin cancer
United States
u.s. food and drug administration

Click the tags to see associated articles and topics

View Article Details
Refining Adjuvant Immunotherapy Use is a Crucial Focus in Early-Stage NSCLC - OncLive

Added to Collection on: 2024-08-03 07:17:00

Tags for this article:

Orphan drugs
Antineoplastic drugs
Lung cancer
Cancer treatments
Tyrosine kinase receptors
Adjuvant therapy
Non-small-cell lung cancer
Alectinib
Pembrolizumab
Nivolumab
Anaplastic lymphoma kinase
Epidermal growth factor receptor

Click the tags to see associated articles and topics

View Article Details
The OncFive: Top Oncology Articles for the Week of 8/18 - OncLive

Added to Collection on: 2024-08-24 15:09:16

Tags for this article:

Orphan drugs
Antineoplastic drugs
Lung cancer
Acrylamides
Cancer immunotherapy
Pembrolizumab
Amivantamab
Nivolumab
Osimertinib
Non-small-cell lung cancer
Melanoma
Epidermal growth factor receptor

Click the tags to see associated articles and topics

View Article Details
ESMO 2024: Tecentriq/Avastin's prospects as the first HCC adjuvant therapy fade

Added to Collection on: 2024-09-15 15:21:28

Tags for this article:

Orphan drugs
Antineoplastic drugs
Infectious causes of cancer
Hepatology
Cancer immunotherapy
Atezolizumab
Pembrolizumab
Nivolumab
Hepatocellular carcinoma
Liver cancer
Durvalumab
Adjuvant therapy
Avastin

Click the tags to see associated articles and topics

View Article Details
First-Line Combo Yields Strong Results in Advanced Sarcoma

Added to Collection on: 2024-09-21 10:11:02

Tags for this article:

Orphan drugs
Sarcoma
Antineoplastic drugs
Soft tissue disorders
Ipilimumab
Nivolumab
Trabectedin
Liposarcoma
Undifferentiated pleomorphic sarcoma
Soft-tissue sarcoma
Melanoma
Programmed cell death protein 1

Click the tags to see associated articles and topics

View Article Details
Nivolumab Drugs Market Overall Study Report 2024-2032 | AbbVie, - openPR.com

Added to Collection on: 2024-09-21 16:57:13

Tags for this article:

Market structure
Antineoplastic drugs
Marketing
Orphan drugs
Business process
Nivolumab
Market research
Market share
Market segmentation
Bristol-Myers Squibb
Competition

Click the tags to see associated articles and topics

View Article Details
September 2024 FDA Roundup: Key Decisions Drive Oncology Forward

Added to Collection on: 2024-10-02 21:06:41

Tags for this article:

Orphan drugs
Antineoplastic drugs
Cancer immunotherapy
Immunology
Pembrolizumab
Atezolizumab
Regenerative Medicine Advanced Therapy
Trastuzumab
Nivolumab
Amgen
Adobe

Click the tags to see associated articles and topics

View Article Details
Cold and hot tumors: from molecular mechanisms to targeted therapy - Nature

Added to Collection on: 2024-10-17 23:38:19

Tags for this article:

Immune system
Clusters of differentiation
T cells
Cancer immunotherapy
Orphan drugs
Checkpoint inhibitor
Programmed cell death protein 1
Ipilimumab
PD-1 and PD-L1 inhibitors
Tumor microenvironment
PD-L1
Nivolumab

Click the tags to see associated articles and topics

View Article Details